Viewing Study NCT00978250

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:07 PM
Ignite Modification Date: 2026-02-28 @ 12:02 AM
Study NCT ID: NCT00978250
Status: COMPLETED
Last Update Posted: 2019-12-27
First Post: 2009-09-15
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU)
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Neoplasms View
None Lung Neoplasms View
None Urinary Bladder Neoplasms View
None Breast Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None DNA Methylation View
None Advanced Cancer View
None Methyltransferase Inhibitor View
None Epigenetics View
None Gene Re-Expression View
None Breast Cancer View
None Head and Neck Cancer View
None Lung Cancer View
None Non-Small Cell Lung Cancer View
None Bladder Cancer View